Although GRP78/BiP levels are elevated in many cancer cells and human cancers and closely associated with malignancy, metastasis, and chemotherapeutic resistance [22,23], few studies have evaluated its prognostic significance in patients with breast, lung, gastric, hepatocellular, or prostate cancer [23]. This evidence concerns the gene HSPA5 and prostate carcinoma.